KOSPI · Healthcare · ₩723B
₩8,350+0.60%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Short Volume 2.6% · as of 26.10.26
Among 97 제약 peers
Quarterly Revenue Growth
“주력 치료제 확장과 해외 판매가 다음 성장을 준비해요.”
In the company's words · 2026 2분기 filing